Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Cathie Wood: SEC Staff Understand Bitcoin and Its Merits
-
Peter Thiel’s Fund Cashed Out $1.8 Billion From Bitcoin Before 2022’s Crash
-
Cryptos Brace For Fed Review Amidst Rate Hike Uncertainty
-
$BTC: US Space Force Major’s Book Highlights Bitcoin’s Significance for National Security
-
Cryptos Slide As Jobs Data Dashes Hopes Of A Quick Fed Pivot